跳至主要内容
临床试验/IRCT20191220045830N1
IRCT20191220045830N1尚未招募3 期

Evaluation of therapeutic effect of probiotic supplement to improvement of signs and immunomodulation in patients with asthma

Semnan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • All patients with asthma who have dry- or with slight sputum cough sign.
  • All patients with asthma who have wheezing sign.
  • All patients with asthma who have dyspnea sign.
  • All patients with asthma who sometimes have the chest tightness or pain symptom.

排除标准

  • The patients who have lung infectious diseases such as pneumonia.
  • The patients who have coronary heart disease.
  • The patients who have lung cancer.
  • The patients who have primary immunodeficiency.
  • The patients who have secondary munodeficiency such as HIV.
  • The patients who smoke.
  • The patients who take antibiotics.

研究者

发起方
Semnan University of Medical Sciences

相似试验